Achieve Life Sciences Inc (NASDAQ:ACHV) shares reached a new 52-week low on Friday . The company traded as low as $2.67 and last traded at $2.67, with a volume of 126 shares changing hands. The stock had previously closed at $2.74.
A number of research analysts have weighed in on the company. ValuEngine raised Achieve Life Sciences from a “sell” rating to a “hold” rating in a report on Saturday, June 16th. LADENBURG THALM/SH SH assumed coverage on Achieve Life Sciences in a report on Monday, August 20th. They set a “buy” rating and a $12.00 target price for the company.
The firm has a market cap of $12.56 million, a price-to-earnings ratio of -0.12 and a beta of 1.93.
Achieve Life Sciences (NASDAQ:ACHV) last posted its earnings results on Wednesday, August 8th. The biopharmaceutical company reported ($1.82) earnings per share for the quarter. sell-side analysts predict that Achieve Life Sciences Inc will post -6.61 EPS for the current year.
About Achieve Life Sciences (NASDAQ:ACHV)
Achieve Life Sciences, Inc, a clinical-stage pharmaceutical company, develops and commercializes smoking cessation aids in the United States and internationally. The company offers Cytisine, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms.
Featured Article: What Factors Can Affect Return on Equity?
Receive News & Ratings for Achieve Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Achieve Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.